J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
J.M. Smucker Posts Upbeat Earnings, Joins LexinFintech, Semtech, Arrowhead Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
J.m. Smucker發佈了樂觀的收益,加入了樂信、先科電子、arrowhead pharmaceuticals和其他大型股票,週二股價上漲。
U.S. stocks were mixed, with the Dow Jones index falling more than 200 points on Tuesday.
美國股票漲跌不一,道瓊斯指數在週二下跌超過200點。
Shares of The J. M. Smucker Company (NYSE:SJM) rose sharply during Tuesday's session after the company reported better-than-expected second-quarter financial results and raised its FY25 adjusted EPS guidance with its midpoint above estimates.
在週二的交易中,傑·姆·斯穆克公司(紐交所:SJM)的股票大幅上漲,因該公司發佈了好於預期的第二季度財務報告,並調高了FY25調整後每股收益指引,其中值高於預期。
Smucker shares surged 6.2% to $120.60 on Tuesday.
斯穆克的股票在週二暴漲6.2%,達到了120.60美元。
Here are some other big stocks recording gains in today's session.
以下是今天交易中漲幅較大的其他大股票。
- Hesai Group (NASDAQ:HSAI) shares jumped 59% to $7.55 after the company reported better-than-expected third-quarter sales results.
- Embecta Corp. (NASDAQ:EMBC) gained 30.2% to $18.76 after the company reported better-than-expected fourth-quarter financial results and issued FY25 adjusted EPS guidance above estimates.
- LexinFintech Holdings Ltd. (NASDAQ:LX) surged 22.8% to $4.1750 after the company announced its board approved an amendment for a dividend policy to increase the payout ratio. Also, the company reported third-quarter financial results.
- Semtech Corporation (NASDAQ:SMTC) gained 20.3% to $64.32 as the company reported better-than-expected third-quarter financial results and issued fourth-quarter guidance with its midpoint above estimates.
- Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) gained 18.1% to $22.17 after the company entered into a global licensing and collaboration agreement with Sarepta Therapeutics for multiple clinical and preclinical siRNA programs.
- Neurogene Inc. (NASDAQ:NGNE) shares rose 15% to $25.65.
- SmartRent, Inc. (NYSE:SMRT) gained 13.8% to $1.8450.
- Sangamo Therapeutics, Inc. (NASDAQ:SGMO) gained 12.6% to $2.1850.
- POET Technologies Inc. (NASDAQ:POET) surged 12.2% to $4.77. POET Technologies recently announced plans to expand its capacity.
- Sarepta Therapeutics, Inc. (NASDAQ:SRPT) shares gained 9.1% to $125.10 after the company announced a global licensing and collaboration agreement with Arrowhead Pharmaceuticals for multiple clinical and preclinical siRNA programs.
- NRG Energy, Inc. (NYSE:NRG) gained 8% to $99.21 after Jefferies upgraded the stock from Hold to Buy and raised its price target from $93 to $113.
- Exact Sciences Corporation (NASDAQ:EXAS) surged 7.8% to $59.45. The company announced it will present 10 abstracts at SABCS.
- Woodward, Inc. (NASDAQ:WWD) surged 7.4% to $192.62 after the company reported better-than-expected fourth-quarter EPS and sales.
- Rocket Lab USA, Inc. (NASDAQ:RKLB) gained 7.3% to $25.82.
- Hanesbrands Inc. (NYSE:HBI) gained 5.8% to $8.94. UBS analyst Jay Sole upgraded Hanesbrands from Neutral to Buy and raised the price target from $9 to $11.
- 禾賽集團(納斯達克:HSAI)的股票在公司發佈了好於預期的第三季度銷售結果後,跳漲59%,達到了7.55美元。
- Embecta公司(納斯達克:EMBC)在發佈了好於預期的第四季度財務結果併發布FY25調整後每股收益指引高於預期後,股價上漲30.2%,達到了18.76美元。
- 樂信控股有限公司(納斯達克:LX)的股票上漲22.8%,達到了4.1750美元,因爲該公司宣佈其董事會批准了一項修正案,以提高股息政策的分配率。此外,該公司發佈了第三季度財務結果。
- 先科電子(納斯達克:SMTC)的股票上漲20.3%,達到64.32美元,因爲該公司發佈了好於預期的第三季度財務結果,並給出了第四季度的預期指引,其中值高於預期。
- 箭頭製藥公司(納斯達克:ARWR)股價上漲18.1%,達到22.17美元,此前該公司與Sarepta Therapeutics簽署了一項全球許可和合作協議,涉及多個臨床和臨床前siRNA項目。
- 神經基因公司(納斯達克:NGNE)股價上漲15%,達到25.65美元。
- SmartRent, Inc.(紐交所:SMRT)股價上漲13.8%,達到1.8450美元。
- Sangamo Therapeutics, Inc.(納斯達克:SGMO)股價上漲12.6%,達到2.1850美元。
- POEt Technologies Inc.(納斯達克:POET)股價暴漲12.2%,達到4.77美元。POEt Technologies最近宣佈計劃擴大其產能。
- Sarepta Therapeutics, Inc.(納斯達克:SRPT)股價上漲9.1%,達到125.10美元,此前該公司宣佈與箭頭製藥簽署了一項全球許可和合作協議,涉及多個臨床和臨床前siRNA項目。
- NRG Energy, Inc.(紐交所:NRG)股價上漲8%,達到99.21美元,此前Jefferies將該股票評級從持有上調至買入,並將其目標價從93美元上調至113美元。
- 精密科學公司(納斯達克:EXAS)股價上漲7.8%,達到59.45美元。該公司宣佈將在SABCS會議上展示10篇摘要。
- 伍德沃德公司(納斯達克:WWD)上漲7.4%,達192.62美元,此前該公司公佈的第四季度每股收益和銷售額均好於預期。
- 火箭實驗室美國公司(納斯達克:RKLB)上漲7.3%,至25.82美元。
- 哈尼斯品牌服裝公司(紐交所:HBI)上漲5.8%,達8.94美元。瑞銀分析師Jay Sole將哈尼斯品牌服裝的評級從中立上調至買入,並將目標價格從9美元上調至11美元。
Now Read This:
現在閱讀這個:
- Starbucks To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday
- 星巴克會漲幅達到13%嗎?以下是星期二的10位頂尖分析師預測
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。